JBM  Vol.6 No.2 , February 2018
High Incidence of Pulmonary Tuberculosis in ART Naive Remunerated Blood Donors with Human Immunodeficiency Virus Type-1 Infection: Possible Role of Iron Overload
Abstract: Iron overload is reported to be associated with immune alterations and increased susceptibility to infections. HIV infection is characterized by progressive immunodeficiency leading to invasion by opportunistic pathogens. It was of interest to find out if disease course in HIV type-1 infection could have any relation with alteration in body iron status among individuals with history of oral iron intake. A follow-up study of immunologic and virologic markers in relation to disease progression was undertaken on asymptomatic HIV-1 positive blood donors with history of oral iron intake (subgroup I) compared to those without such history (subgroup II). High serum iron was associated with elevated levels of Th2 category of cytokines, heightened immune activation, faster decline in CD4 + T lymphocyte count and higher viral set point. Pulmonary tuberculosis (PT) was the most common AIDS related illness (ARI) (>70%) recorded among subgroup I compared to non-PT category of ARI. Median ARI free duration (months) was shorter among those who developed PT compared to those developing non-PT category of ARI i.e. 30 (95% CI as 26,32) versus 67(95% CI as 60,71) in subgroup I and 47 (95% CI as 42,49) versus 80 (95% CI as 72,87) in subgroup II (P < 0.001 for PT versus non-PT in both subgroups). Median survival duration (months) in the PT versus non-PT categories of ARI was 47 (95% CI as 42,48) versus 95 (95% CI as 90,100) in subgroup I and 71 (95% CI as 65,76) versus 107 (95% CI as 102,112) in subgroup II (P < 0.001 for PT versus non-PT in both subgroups). The present study indicates that body iron overload resulting from excess intake of iron may be associated with qualitative defects in cell mediated immunity at early stage of HIV-1 infection that may facilitate subsequent acquisition of pulmonary tuberculosis, shorter ARI free duration and reduced survival.
Cite this paper: Chattopadhya, D. , Baveja, U. (2018) High Incidence of Pulmonary Tuberculosis in ART Naive Remunerated Blood Donors with Human Immunodeficiency Virus Type-1 Infection: Possible Role of Iron Overload. Journal of Biosciences and Medicines, 6, 62-82. doi: 10.4236/jbm.2018.62006.

[1]   Chattopadhya, D., Riley, L.W. and Kumari, S. (1991) Behavioral Risk Factors for Acquisition of HIV Infection and Knowledge about AIDS among Male Professional Donors in Delhi. Bulletin of the World Health Organization, 69, 319-323.

[2]   Singh, R., Kapur, S. and Mittal, A. (1995) Rising Trend of HIV Positive Individuals among Blood Donors in Delhi. Indian Journal of Sexually Transmitted Diseases, 16, 15-17.

[3]   Wadia, M.R. and Karve, S.R. (1992) Rising Trend of HIV Infection with Special Reference to Blood Donors. The Journal of the Association of Physicians of India, 40, 513-515.

[4]   Kumarswamy, N., Solomon, S., Flanigan, T.P., Hemlatha, R., Thyagarajan, S.P. and Mayer, K.H. (2003) Natural History of Human Immunodeficiency Virus Disease in Southern India. CID, 36, 79-85.

[5]   Swami, O.S., Chattopadhya, D., Grover, G., Kumar and Baveja, U.K. (2006) Role of HCV Co-Infection towards Disease Progression and Survival in HIV-I Infected Children: A Follow up Study of 10 Years. Journal of Tropical Pediatrics, 52, 206-211.

[6]   Swami, O.S., Chattopadhya, D. and Grover, G. (2007) Nonparametric Estimation of the Incubation Period of AIDS with Left Truncation and Right Censoring. Journal of Data Science, 5, 289-296.

[7]   Amo, J.D., Petruckevitch, A., Phillips, A., Johnson, A.M., Stephenson, J., Desmond, M., Hanscheid, T., et al. (1998) Disease Progression and Survival in HIV-1 Infected Africans in London. AIDS, 12, 1203-1209.

[8]   Enger, C., Graham, N., Peng, Y., Chmiel, J.S., Kingsley, L.A., Detels, R., et al. (1996) Survival from Early, Intermediate, and Late Stage of HIV Infection. JAMA, 275, 1329-1334.

[9]   Guenter, P., Muurahainen, N., Simons, G., Kosok, A., Cohan, G.R., Rudenstein, R., et al. (1993) Relationship among Nutritional Status, Disease Progression and Survival in HIV Infection. Journal of Acquired Immune Deficiency Syndromes, 6, 1130-1138.

[10]   Leng, Q., Borkow, G., Weisman, Z., Stein, M., Kalinkovich, A. and Bentwich, Z. (2001) Immune Activation Correlates Better than HIV Plasma Viral Load with CD4 T Cell Decline during HIV Infection. Journal of Acquired Immune Deficiency Syndromes, 27, 389-397.

[11]   Deeks, S.G., Kitchen, C.M., Liu, L., Guo, H., Gascon, R., Narvaez, A.B., et al. (2004) Immune Activation Set Point during Early HIV Infection Predicts Subsequent CD4+ T Lymphocyte Changes In-dependent of Viral Load. Blood, 104, 942-947.

[12]   Hazerberg, M.D., Otto, S.A., van Benthem, B.H., Ross, M.T., Coutinho, R.A., Langer, J.M., et al. (2003) Persistent Immune Activation in HIV-1 Infection Is Associated with Progression to AIDS. AIDS, 17, 1881-1888.

[13]   Chattopadhya, D., Aggarwal, R., Sen, S., Kumari, S. and Verghese, T. (1996) Lack of Evidence of HIV-2 Infection among Multi-Transfused Thalassemic Children in the City of Delhi. Journal of Tropical Pediatrics, 42, 116-117.

[14]   Indian Council of Medical Research (1999) Nutritional Requirements and Recommended Dietary Allowances for Indians. National Institute of Nutrition, Hyderabad.

[15]   Chattopadhya, D., Saha, K., Chakrabarty, A.K., Rao, K.N., Patil, S.K. and Dusaj, I.S. (1992) Nutritional Status of Children of Urban Leprosy Patients Staying at Preventoria Based on Biochemical Parameters. European Journal of Clinical Nutrition, 46, 885-895.

[16]   Aggarwal, V., Prakash, C., Yadav, S. and Chattopadhya, D. (1997) Prevalence of Transfusion Associated Infection in Multi-Transfused Children in Relation to Mandatory Screening of Human Immunodeficiency Virus (HIV) Infection in Donated Blood. The Southeast Asian Journal of Tropical Medicine and Public Health, 28, 699-706.

[17]   Chattopadhya, D., Baveja, U.K., Bose, M. and Kumar, A. (2002) Disease Progression Marker during Asymptomatic Phase of HIV-1 Infected Children with CD4+ Lymphocyte Values: Evaluation of Repeat CD4+ Lymphocyte vs. Other Immunological Parameters. Journal of Tropical Pediatrics, 48, 340-347.

[18]   World Health Organization (1994) Expanded WHO Case Definition for AIDS Surveillance in Adults and Adolescents. The Weekly Epidemiological Record, 69, 273-275.

[19]   Fischbach, F.T. and Dunning, M.B. (2009) A Manual of Laboratory and Diagnostic Tests. Lippincott Williams & Wilkins, Philadelphia.

[20]   Morgan, D., Maude, G.H., Malamba, S., Okongo, M.J., Wagner, H.U., Mulder, D.W., et al. (1997) HIV-1 Disease Progression and AIDS Defining Disorder in Rural Uganda. The Lancet, 350, 245-250.

[21]   Whalen, C.C., Nsubuga, P., Okwera, A., Johnson, J.L., Hom, D.L., Michael, N.L., et al. (2000) Impact of Pulmonary Tuberculosis on Survival of HIV-Infected Adults: A Prospective Epidemiologic Study in Uganda. AIDS, 14, 1219-1228.

[22]   Rosner, B. (2000) Fundamentals of Biostatistics. 5th Edition, Duxbury Press, Belmont.

[23]   World Health Organization (2002) Safe Blood and Blood Products, Module 1. WHO, Geneva.

[24]   Director General of Health Services (1988) Development Strategies on Blood Transfusion Service in India. DGHS, New Delhi.

[25]   Powell, L.W. (2005) Hemochromatosis. In: Kasper, D.L., Braunwald, E. and Fauci, A.S., Eds., Harrison’s Principle of Internal Medicine, 16th Edition, Vol. 2, Chapter 342, McGraw-Hill, New York.

[26]   Alleyne, M., Horne, M.K. and Miller, J.L. (2008) Individualized Treatment for Iron Deficiency Anemia in Adults. American Journal of Medicine, 121, 943-948.

[27]   Guyton, A.C. and Hall, J.E. (2006) Textbook of Medical Physiology. 11th Edition, W.B. Saunders Company, Harcourt Asia Pvt Ltd., Singapore.

[28]   Duane, P., Raja, K.B., Simpson, R.J. and Peters, T.J. (1992) Intestinal Iron Absorption in Chronic Alcoholics. Alcohol and Alcoholism, 27, 539-544.

[29]   Gordeuk, V.R. (1992) Hereditary and Nutritional Overload. Baillière’s Clinical Haematology, 5, 169-176.

[30]   Moyo, V.M., Mandishona, E., Hasstedt, S.J., Gangaidzo, I.T., Gomo, Z.A., Khumalo H., et al. (1998) Evidence of Genetic Transmission in African Iron over Load. Blood, 91, 1076-1082.

[31]   Gordeuk, V.R., Boyd, R.D. and Brittenham, G.M. (1986) Dietary Iron Overload Persists in Rural Sub-Saharan Africa. The Lancet, 1, 1310-1313.

[32]   Friedman, B.M., Baynes, R.D., Bothwell, T.H., Gordeuk, V.R., Macfarlane, B.J., Lamparelli, R.D., et al. (1990) Dietary Iron Overload in South African Rural Blacks. South African Medical Journal, 78, 301-305.

[33]   Langford, S.E., Ananworanich, J. and Cooper, D.A. (2007) Predictors of Disease Progression in HIV Infection: A Review. AIDS Research and Therapy, 4, 11.

[34]   Lepri, A.C., Sabin, C.A., Pizzotti, P., England, P.D., Phillips, A.N. and Razza, G. (1997) Is There a General Tendency for CD4 Lymphocyte Decline to Speed up during Human Immunodeficiency Virus Infection? Evidence from Italian Seroconversion Study. The Journal of Infectious Diseases, 175, 775-780.

[35]   CASCADE Collaboration (2000) Time from HIV-1 Sero-Conversion to AIDS and Death before Widespread Use of Highly Active Antiretroviral Therapy: A Collaborative Reanalysis. The Lancet, 355, 1131-1137.

[36]   Lavreys, L., Baeten, J.M., Chohan, V., McClelland, R.S., Hassen, W.M., Richardson, B.A., et al. (2006) Higher Set Point Plasma Viral Load and More Severe Acute HIV Type1 (HIV-1) Illness Predict Mortality among High Risk HIV-1 Infected African Woman. Clinical Infectious Diseases, 42, 1333-1339.

[37]   Miedema, F., Petit, A.J., Terpstra, F.G., Schattenkerk, J.K., de Wolf, F., Al, B.J., et al. (1988) Immunological Abnormalities in Human Immunodeficiency Virus (HIV)-Infected Asymptomatic Homosexual Men. The Journal of Clinical Investigation, 82, 1908-1914.

[38]   Morgan, D., Mahe, C., Mayanja, B. and Whitworth, J.A.G. (2002) Progression to Symptomatic Disease in People Infected in HIV-1 Infection in Rural Uganda: Prospective Cohort Study. BMJ, 324, 193-196.

[39]   Raviglione, M.C., Narain, J.P. and Kochi, A. (1992) HIV-Associated Tuberculosis in Developing Countries: Clinical Features, Diagnosis and Treatment. Bulletin of the World Health Organization, 70, 515-526.

[40]   Barnes, P.F., Bloch, A.B., Davidson, P.T. and Snider, D.E. (1991) Tuberculosis in Patients with Human Immunodeficiency Virus Infection. The New England Journal of Medicine, 324, 1644-1650.

[41]   Orme, I.M., Anderson, P. and Boom, W.H. (1993) Lymphocyte Response to Mycobacterium tuberculosis. The Journal of Infectious Diseases, 167, 1481-1487.

[42]   Leroy, V., Salmi, L.R., Dupon, M., Sentilhes, A., Texier-Maugien, J., Dequae, L., et al. (1997) Progression of Human Immunodeficiency Virus in Patients with Tuberculosis Disease. American Journal of Epidemiology, 145, 293-300.

[43]   Ackah, A.N., Coubibaly, D., Digbeu, H., Diallo, K., Vetter, K.M., Coulibaly, I.M., et al. (1995) Response to Treatment, Mortality and CD4 Lymphocyte Counts in HIV-Infected Patients with Pulmonary Tuberculosis in Abidjan, Cote d’lvoire. The Lancet, 345, 607-610.

[44]   Anzala, O.A., Nagelkerke, N.J., Bwayo, J.J., Holton, D., Moses, S., Ngugi, E.N., et al. (1995) Rapid Progression to Disease in African Sex Workers with Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases, 171, 686-689.

[45]   Deschamps, M.M., Fitzgerald, D.W., Pape, J.W. and Johnson, W.D. (2000) HIV Infection in Haiti: Natural History and Disease Progression. AIDS, 14, 2515-2521.

[46]   Cronje, L., Edmondson, N., Eisenach, K.D. and Bornman, L. (2005) Iron and Iron Chelating Agents Modulate Mycobacterium tuberculosis Growth and Monocyte-Macrophage Viability and Effector Functions. FEMS Immunology & Medical Microbiology, 45, 103-112.

[47]   Sappey, C., Boelaert, J.R., Legrand-Poels, S., Forceille, C., Favier, A. and Piette, J. (1995) Iron Chelation Decreases NF-kB and HIV Type-1 Activation Due to Oxidative Stress. AIDS Research and Human Retroviruses, 11, 1049-1061.

[48]   Gangaidzo, I.T., Moyo, V.M., Mvundura, E., Aggrey, G., Murphree, N.L., Khumalo, H., et al. (2001) Association of Pulmonary Tuberculosis with Increased Dietary Iron. The Journal of Infectious Diseases, 184, 936-939.

[49]   De Sousa, M. (1989) Immune Lymphocyte Function in Iron Overload. Clinical & Experimental Immunology, 75, 1-6.